Psyence Group (GCR) AI Stock Analysis

8 Followers

Psyence Group

(CNQX:GCR)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Enhanced Research CapabilitiesAppointing a new chair enhances research capabilities in psilocybin-based treatments, supporting long-term development and innovation in psychedelic therapeutics.

Negative Factors

Lack of Revenue GenerationThe absence of revenue generation and negative profit margins reflect stagnant financial performance, challenging the company's ability to achieve profitability and sustain growth.

Psyence Group (GCR) vs. iShares MSCI Canada ETF (EWC)

Market Cap: CAD 4.82M
Dividend Yield: ―
Average Volume (3M): 32.31K
Price to Earnings (P/E): -0.5
Beta (1Y): 0.26
Revenue Growth: ―
EPS Growth: 97.23%
Country: Canada
Employees: 5
Sector: Healthcare
Sector Strength: 51
Industry: Gold

Psyence Group Business Overview & Revenue Model

Company Description

GoldCoast Resource Corp. engages in the exploration of gold deposits in Ghana. The company is based in Toronto, Canada.

How the Company Makes Money

null

Psyence Group Technical Analysis

Technical Analysis SentimentNegative

Last Price0.47

Price Trends

50DMA0.66Negative

100DMA0.75Negative

200DMA0.79Negative

Market Momentum

MACD-0.05Negative

RSI33.68Neutral

STOCH50.00Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:GCR, the sentiment is Negative. The current price of 0.47 is below the 20-day moving average (MA) of 0.49, below the 50-day MA of 0.66, and below the 200-day MA of 0.79, indicating a bearish trend. The MACD of -0.05 indicates Negative momentum. The RSI at 33.68 is Neutral, neither overbought nor oversold. The STOCH value of 50.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:GCR.

Psyence Group Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

TSE:GCR against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
TSE:RVV	39Underperform	CAD 8.89M	-16.67	26.78%	―	―	90.84%

* Healthcare Sector Average

Performance Comparison

TSE:GCR and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
TSE:GCR	Psyence Group Inc.	0.47	-0.30	-38.56%
TSE:RVV	Revive Therapeutics	0.02	0.01	100.00%
TSE:MYND	Mynd Life Sciences Inc	0.07	0.00	0.00%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Psyence Group AI Stock Analysis